Prof. Dr. CEYDA TUBA ŞENGEL TÜRK

Yayın Ağı

Makaleler 49

1. Development and in vivo evaluation of a novel semi-solid nanostructured lipid carrier of fluticasone propionate for the treatment of atopic dermatitis using a quality by design approach

Amasya G., Badilli U., Şengel Türk C. T., Onay-Besikci A., Aksu B., Tarimci N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.114, 2025 (SCI-Expanded, Scopus)

2. Quantification and Engineering of Lipid Nanocapsule Formulations for the Delivery of Niclosamide as an Anti-Cancer Drug

Demirtaş H., Tok K. C., Gümüştaş M., Şengel Türk C. T.

CURRENT PHARMACEUTICAL DESIGN , 2025 (SCI-Expanded, Scopus)

3. Rhoifolin: a promising flavonoid with cytotoxic and anticancer properties – molecular mechanisms and therapeutic potential

Kılıç C. S., Kışla M. M., Amasya Çelikten G., Şengel Türk C. T., Alagöz Z., Gençler Özkan A. M., et al.

EXCLI JOURNAL , cilt.24, sa.24, ss.289-320, 2025 (SCI-Expanded, Scopus)

4. Rational design of a Nano-Antibiotic chitosan hydrogel for the bacterial infection Therapy: In vitro & ex vivo Assessments

Amasya Çelikten G., Şengel Türk C. T., Erol H. B., Kaşkatepe B., Öncü A., Guney-Eskiler G., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.665, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Nanocrystals and their applications in pharmaceutical technology: An up-to-date overview

DELJAVAN GHODRATI A., ŞENGEL TÜRK C. T.

JOURNAL OF RESEARCH IN PHARMACY , cilt.28, sa.6, ss.1921-1935, 2024 (ESCI)

6. Electrospun nanofibers: building blocks for the repair of bone tissue

SERİM T. M., AMASYA ÇELİKTEN G., Eren-Boncu T., ŞENGEL TÜRK C. T., Ozdemir A. N.

BEILSTEIN JOURNAL OF NANOTECHNOLOGY , ss.941-953, 2024 (SCI-Expanded, Scopus)

7. Effect of Trastuzumab and Lonidamine-Loaded Lipid Nanoparticles (LNP) on HER2+ Breast Cancer

Ozlem Zurnaci F., Ozdatli Kurtulus S., ŞENGEL TÜRK C. T., HASÇİÇEK C., GÜZEL M.

ChemistrySelect , cilt.9, sa.22, 2024 (SCI-Expanded)

8. The state of the art in core–shell-type lipid–polymer hybrid nanocarriers and beyond

ŞENGEL TÜRK C. T., Paksoy A. O., Alptürk O.

Polymer Bulletin , cilt.81, sa.6, ss.4771-4800, 2024 (SCI-Expanded)

9. Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy

Aytar Çelik P., Erdogan-Gover K., Barut D., Enuh B. M., Amasya G., Sengel-Türk C. T., et al.

PHARMACEUTICS , cilt.15, sa.4, 2023 (SCI-Expanded, Scopus)

10. CORE SHELL TYPE LIPID POLYMER HYBRID NANOCARRIERS AS A NOVEL-GENERATION DRUG DELIVERY PLATFORM

ŞENGEL TÜRK C. T.

JOURNAL OF RESEARCH IN PHARMACY , cilt.27, ss.1-3, 2023 (ESCI)

11. Capecitabine-loaded bacterial membrane vesicles derived from Enterococcus faecalis promotes apoptosis in HT-29 colon cancer cells

Erdogan Gover K., Isik M., Barut D., ŞENGEL TÜRK C. T., AMASYA G., DERKUŞ B., et al.

Biochemical Engineering Journal , cilt.189, 2022 (SCI-Expanded, Scopus)

12. Lonidamine loaded Poly(ethylene glycol)-block-poly(epsilon-caprolacton) nanocarriers inhibited the proliferation of colorectal cancer cells through G0/G1 cell cycle arrest

BAKAR ATEŞ F., ŞENGEL TÜRK C. T.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.77, 2022 (SCI-Expanded, Scopus)

13. Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples

Tok K. C., Gümüştaş M., Şengel Türk C. T., Amasya G., Bayram B., Arıoğlu İnan E.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS , 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Box-Behnken design optimization and in vitro cell based evaluation of piroxicam loaded core-shell type hybrid nanocarriers for prostate cancer

ŞENGEL TÜRK C. T., Ozkan E., BAKAR ATEŞ F.

Journal of Pharmaceutical and Biomedical Analysis , cilt.216, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. NEW GENERATION LIPID-BASED DRUG DELIVERY SYSTEMS: LIPID NANOCAPSULES YENİ NESİL LİPİT BAZLI İLAÇ TAŞIYICI SİSTEMLER: LİPİT NANOKAPSÜLLER

DEMİRTAŞ H., ŞENGEL TÜRK C. T.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.46, sa.1, ss.239-261, 2022 (Scopus)

16. Nanofibers as implantable controlled release systems, Polymer science,

Serim T. M., Eren Böncü T., Amasya G., Şengel Türk C. T., Özdemir A. N.

Polymer Science-PSPRJ , cilt.2, sa.5, 2022 (Hakemli Dergi)

17. Design, characterization and evaluation of cucurbitacin B-loaded core-shell-type hybrid nano-sized particles using DoE approach

ŞENGEL TÜRK C. T., ÖZMEN N., BAKAR ATEŞ F.

POLYMER BULLETIN , cilt.78, sa.6, ss.3327-3351, 2021 (SCI-Expanded, Scopus)

18. Gold nanoparticules and uses in cancer Altin nanopartiküller ve kanserde kullanimlari

DEMİRTAŞ H., ŞENGEL TÜRK C. T.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.45, sa.1, ss.70-95, 2021 (Scopus)

19. Development and in-vitro evaluation of chitosan chloride decorated PLGA based polymeric nanoparticles of nimesulide

ŞENGEL TÜRK C. T., Bayram B.

JOURNAL OF RESEARCH IN PHARMACY , cilt.25, sa.4, ss.379-387, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

20. Clinicopathological and immunohistochemical evaluation of lonidamine-entrapped lipid-polymer hybrid nanoparticles in treatment of benign prostatic hyperplasia: An experimental rat model

ŞENGEL TÜRK C. T., ALÇIĞIR M. E., EKİM O., BAKAR ATEŞ F., HASÇİÇEK C.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS , cilt.157, ss.211-220, 2020 (SCI-Expanded, Scopus)

21. Development and Statistical Optimization of Solid Lipid Nanoparticle Formulations of Fluticasone Propionate

AMASYA G., ŞENGEL TÜRK C. T., Badilli U., Tarimci N.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.4, ss.359-366, 2020 (ESCI, Scopus, TRDizin)

22. Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage

BAKAR ATEŞ F., Ozkan E., ŞENGEL TÜRK C. T.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.586, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. SLN enriched hydrogels for dermal application: Full factorial design study to estimate the relationship between composition and mechanical properties

AMASYA G., İNAL Ö., ŞENGEL TÜRK C. T.

CHEMISTRY AND PHYSICS OF LIPIDS , cilt.228, 2020 (SCI-Expanded, Scopus)

24. Effects of Lonidamine-Loaded Lipid-Polymer Hybrid Nanoparticles on Cardiac Fibrosis Induced By High-Dose Testosterone Propionate In Adult and Neutered Male Rats

ALÇIĞIR M. E., ŞENGEL TÜRK C. T., HASÇİÇEK C., EKİM O.

Kocatepe Veterinary Journal , cilt.11, sa.4, ss.402-413, 2018 (Hakemli Dergi)

25. Design and in-vitro cell-based evaluation of lonidamine-loaded vitamin E TPGS-conjugated polymeric nanoparticles

Bakar-Ates F., ŞENGEL TÜRK C. T.

FEBS OPEN BIO , cilt.8, ss.249, 2018 (SCI-Expanded)

26. Fulvestrant-loaded polymer-based nanoparticles for local drug delivery: Preparation and in vitro characterization

Hascicek C., ŞENGEL TÜRK C. T., GÜMÜŞTAŞ M., Ozkan A. S., Bakar F., Das-Evcimen N., et al.

Journal of Drug Delivery Science and Technology , cilt.40, ss.73-82, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Design of lipid-polymer hybrid nanoparticles for therapy of BPH: Part I. Formulation optimization using a design of experiment approach

ŞENGEL TÜRK C. T., HASÇİÇEK C.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.39, ss.16-27, 2017 (SCI-Expanded, Scopus)

28. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells

ŞENGEL TÜRK C. T., HASÇİÇEK C., BAKAR ATEŞ F., Simsek E.

AAPS PHARMSCITECH , cilt.18, sa.2, ss.393-403, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Novel Drug Delivery System for Dermal Uptake of Etofenamate: Semisolid SLN Dispersion

BADILLI F. U., ŞENGEL TÜRK C. T., AMASYA G., Tarimci N.

CURRENT DRUG DELIVERY , cilt.14, sa.3, ss.386-393, 2017 (SCI-Expanded, Scopus)

30. Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems

Gümüştaş M., Şengel Türk C. T., Gumustas A., Ozkan S. A., Uslu B.

MULTIFUNCTIONAL SYSTEMS FOR COMBINED DELIVERY, BIOSENSING AND DIAGNOSTICS , ss.67-108, 2017 (SCI-Expanded)

31. Optimization of Stability Indicating LC Method for the Sensitive In vitro Determination from Solid Lipid Nanoparticles and Ex vivo Analysis from Rat Skin of Etofenamate

Gümüştaş M., Şengel Türk C. T., Badıllı F. U., Amasya G., Özkan S. A., Tarimci N.

CURRENT PHARMACEUTICAL ANALYSIS , cilt.13, sa.1, ss.63-71, 2017 (SCI-Expanded, Scopus)

32. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL

UĞURLU T., Nalbantoglu A., ŞENGEL TÜRK C. T.

ACTA POLONIAE PHARMACEUTICA , cilt.73, sa.6, ss.1631-1638, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Influence of polymer molecular weight on in-vitro characteristics and cytotoxicity of fulvestrant loaded nanoparticles

Hasçiçek C., Şengel Türk C. T., Gümüştaş M., Özkan S. A., Bakar Ateş F., Das-Evcimen N., et al.

Current Drug Therapy , cilt.9, sa.4, ss.239-249, 2015 (Scopus) Sürdürülebilir Kalkınma

34. Development of Etofenamate-Loaded Semisolid SLN Dispersions and Evaluation of Anti-Inflammatory Activity for Topical Application

BADILLI F. U., ŞENGEL TÜRK C. T., BEŞİKCİ A., Tarimci N.

CURRENT DRUG DELIVERY , cilt.12, sa.2, ss.200-209, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Optimization of a validated stability-indicating RP-LC method for the determination of fulvestrant from polymeric based nanoparticle systems, drugs and biological samples

Gümüştaş M., Şengel Türk C. T., Hasçiçek C., Özkan S. A.

BIOMEDICAL CHROMATOGRAPHY , cilt.28, sa.10, ss.1409-1417, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Formulation and Optimization of Nonionic Surfactants Emulsified Nimesulide-Loaded PLGA-Based Nanoparticles by Design of Experiments

ŞENGEL TÜRK C. T., ÖZ U. C., SERİM T. M., HASÇİÇEK C.

AAPS PHARMSCITECH , cilt.15, sa.1, ss.161-176, 2014 (SCI-Expanded, Scopus)

37. Influence of Polymer Molecular Weight on In Vitro Characteristics And Anti Tumor Activities of Fulvestrant Encapsulated PLGA Nanoparticles

Hasçiçek C., Sengel Türk C. T., Gümüştaş M., Özkan A. S., Bakar F., Daş Evcimen N., et al.

CURRENT DRUG THERAPY , cilt.9, sa.4, ss.239-249, 2014 (Scopus)

38. Surface modification and evaluation of PLGA nanoparticles: the effects on cellular uptake and cell proliferation on the HT-29 cell line

ŞENGEL TÜRK C. T., Hascicek C., Dogan A. L., ESENDAĞLI G., Guc D., Gonul N.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.24, sa.2, ss.166-172, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

39. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells

ŞENGEL TÜRK C. T., HASÇİÇEK C., Dogan A. L., ESENDAĞLI G., Guc D., Gonul N.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.38, sa.9, ss.1107-1116, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Ethylcellulose-Based Matrix-Type Microspheres: Influence of Plasticizer RATIO as Pore-Forming Agent

ŞENGEL TÜRK C. T., HASÇİÇEK C., Gonul N.

AAPS PHARMSCITECH , cilt.12, sa.4, ss.1127-1135, 2011 (SCI-Expanded, Scopus)

41. Design of vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-emulsified poly (D,L-Lactide-co-glycolide) nanoparticles: Influence of duration of ultrasonication energy

ŞENGEL TÜRK C. T., HASÇİÇEK C., Gönül N.

Journal of Young Pharmacists , cilt.3, sa.3, ss.171-175, 2011 (ESCI)

42. VITAMIN E TPGS COATED BIODEGRADABLE POLYMERIC NANOPARTICLES OF MELOXICAM FOR COLON-SPECIFIC DELIVERY

ŞENGEL TÜRK C. T., HASÇİÇEK C., Gonul N.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.38, sa.1, ss.103-105, 2009 (SCI-Expanded)

43. Evaluation of drug-polymer interaction in polymeric microspheres containing diltiazem hydrochloride

Turk C. T., Hascicek C., Gonul N.

Journal of Thermal Analysis and Calorimetry , cilt.95, sa.3, ss.865-869, 2009 (SCI-Expanded, Scopus)

44. Surface modification of polymeric nanoparticulate drug carrier systems Poli̇meri̇k nanoparti̇küler i̇laç taşiyici si̇stemlerde yüzey modi̇fi̇kasyonu

ŞENGEL TÜRK C. T., HASÇİÇEK C.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.38, sa.2, ss.137-154, 2009 (Scopus)

45. Preparation of polymeric nanoparticles using different stabilizing agents

ŞENGEL TÜRK C. T., SEZGİN BAYINDIR Z., BADILLI F. U.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.38, sa.4, ss.257-268, 2009 (Scopus)

46. Microsphere-based once-daily modified release matrix tablets for oral administration in angina pectoris

Sengel-Tuerk C. T., HASÇİÇEK C., Goenuel N.

Journal of Microencapsulation , cilt.25, sa.4, ss.257-266, 2008 (SCI-Expanded, Scopus)

47. Beyne İlaç Hedeflendirilmesinde Nanopartiküler İlaç Taşıyıcı Sistemler

ŞENGEL TÜRK C. T., HASÇİÇEK C., Gönül N.

Journal of Neurological Sciences (Turkish), , cilt.24, sa.3, ss.254-263, 2007 (Hakemli Dergi)

48. Colon targeted drug delivery systems Kolona hedeflenen i̇laç taşiyici si̇stemler

ŞENGEL TÜRK C. T., HASÇİÇEK C., Gönül N.

Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.35, sa.2, ss.125-148, 2006 (Scopus)

49. Development and in-vitro evaluation of modified release tablets including ethylcellulose microspheres loaded with diltiazem hydrochloride

Sengel C. T., HASÇİÇEK C., Gonul N.

Journal of Microencapsulation , cilt.23, sa.2, ss.135-152, 2006 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 66

1. Development and Evaluation of BRAF Inhibitor Loaded Nanofiber Formulations for Targeted Therapy of Malignant Melanoma

Deljavan Ghodrati A., Bozmaoğlu C. H., Amasya Çelikten G., Gümüştaş M., Şengel Türk C. T.

7th International Symposium on Advances in Pharmaceutical Analysis (APA 2025), Ankara, Türkiye, 24 - 27 Ağustos 2025, ss.1, (Özet Bildiri)

2. Development and Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers Emulsified with DOTAP and CTAP for Enhanced Drug Delivery Performance

Deljavan Ghodrati A., Amasya Çelikten G., Şengel Türk C. T.

EMU International Pharmaceutical Sciences Congress 2025 (IPSC 2025) , Gazimagusa, Kıbrıs (Kktc), 14 Mayıs 2025, ss.42, (Özet Bildiri)

3. THE POTENTIAL ROLE OF NANO-BASED DRUG DELIVERY SYSTEMS IN THE TREATMENT OF PROSTATE DISEASES

Şengel Türk C. T.

13th International Drug Chemistry Conference, Antalya, Türkiye, 6 - 09 Şubat 2025, ss.13, (Özet Bildiri)

4. Development of HPLC Method For The Determınatıon of Abemacıclıb From Lıpıdpolymer Hybrıd Nanodelıvery Systems

Gümüştaş M., Bozmaoğlu C. H., Güney G., Şengel Türk C. T.

34th International Symposium on Pharmaceutical and Biomedical Analysis (PBA2024), Geneve, İsviçre, 9 - 12 Eylül 2024, ss.1-400, (Özet Bildiri)

5. Development of HPLC Method for the Determination of Teicoplanin from Polymeric Based Drug Delivery System

Bozmaoğlu C. H., Gümüştaş M., Serim T. M., Şengel Türk C. T., Özdemir A. N.

14th International Symposium on Pharmaceutical Sciences (ISOPS) 2024, Ankara, Türkiye, 25 - 28 Haziran 2024, ss.17-18, (Özet Bildiri)

6. Kök Kanal Dezenfeksiyonu Amacıyla Sentezlenen Nano-antibiyotik Hidrojel

Öncü A., Erol H. B., Çelikten B., Amasya Çelikten G., Şengel Türk C. T., Kaşkatepe B., et al.

27. TÜRK DİŞ HEKİMLERİ BİRLİĞİ ULUSLARARASI DİŞHEKİMLİĞİ KONGRESİ , Ankara, Türkiye, 26 - 29 Ekim 2023, ss.316-317, (Özet Bildiri)

7. Enhancing Anticancer Potential: Optimization of Niclosamide Loaded Lipid Nanocapsules for Improved Delivery and Quantification

Demirtaş H., Tok K. C., Gümüştaş M., Şengel Türk C. T.

33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA2023), Ankara, Türkiye, 2 - 06 Temmuz 2023, ss.84-86, (Tam Metin Bildiri)

8. Development of Salting-out Extraction Method for the Determination of Piroxicam from Polymeric Based Nanocarriers and Biological Samples

Tok K. C., Gümüştaş M., Bayram B., Amasya G., Arıoğlu İnan E., Şengel Türk C. T.

2nd European Sample Preparation e-Conference (EuSP2022), 14 - 16 Mart 2022, ss.1, (Özet Bildiri)

9. IN VIVO EVALUATION ON FLUTICASONE PROPIONATE LOADED SEMI-SOLID LIPID NANOPARTICLE DISPERSIONS

BADILLI F. U., ŞENGEL TÜRK C. T., AMASYA G., ALÇIĞIR M. E., BEŞİKCİ A., AKSU N. B., et al.

20th International Pharmaceutical Technology Symposium – IPTS 2022, Ankara, Türkiye, 21 - 23 Şubat 2022, (Özet Bildiri)

10. A Systematic Screening Design Study for Preparation of Niclosamide Loaded Lipid Nanocapsules

Demirtaş H., Şengel Türk C. T.

20th International Pharmaceutical Technology Symposium (IPTS 2022), Ankara, Türkiye, 21 - 23 Şubat 2022, ss.234, (Özet Bildiri)

11. Optimization of LC Method for the Determination of Fluticasone Propionate from Drug Delivery Systems

Tok K. C., Amasya G., Şengel Türk C. T., Badıllı F. U., Gümüştaş M.

3rd International Gazi Pharma Symposium Series (GPSS2021), Kyoto, Japonya, 08 Eylül 2021, (Özet Bildiri)

12. A NEW PERSPECTIVE FOR DEXPANTHENOL ORALLY DISINTEGRATING FILMS THROUGH DESIGN OF EXPERIMENT APPROACH

İNAL Ö., KALFA N., ŞENGEL TÜRK C. T.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Turkey, 8-10.09.2021, Ankara, Türkiye, 08 Eylül 2021, (Özet Bildiri)

13. Application of Design of Experiment Approach for Optimization of Piroxicam Loaded Polymeric Based Nanocarriers

Bayram B., Şengel Türk C. T.

3rd International Gazi Pharma Symposium Series (GPSS-2021), Ankara, Türkiye, 8 - 10 Eylül 2021, ss.22, (Özet Bildiri)

14. Optimization of HPLC method for the determination of piroxicam from polymeric based nanocarriers and biological samples

Gümüştaş M., Tok K. C., Bayram B., Amasya G., Arıoğlu İnan E., Şengel Türk C. T.

31st International Symposium on Pharmaceutical and Biomedical Analysis, Kyoto, Japonya, 29 Ağustos - 01 Eylül 2021, (Özet Bildiri)

15. ATORVASTATIN-ENCAPSULATED CORE-SHELL TYPE HYBRID NANOCARRIERS FOR LOCAL THERAPY OF BREAST CANCER: FORMULATION AND OPTIMIZATION STUDIES

ŞENGEL TÜRK C. T., BAKAR ATEŞ F.

13th International. Symposium on Pharmaceutical Science, 22 Haziran 2021, (Özet Bildiri)

16. DoE Based Approach for the Design of Piroxicam Loaded Polymeric Nanoparticles

Bayram B., Şengel Türk C. T.

13th International Symposium on Pharmaceutical Sciences (ISOPS-13), Ankara, Türkiye, 22 - 25 Haziran 2021, ss.155, (Özet Bildiri)

17. Design of Experiment (DoE) based optimization and in-vitro cell culture studies of piroxicam loaded hybrid nanoparticles for prostate cancer

ŞENGEL TÜRK C. T., BAKAR ATEŞ F.

EUFEPS Annual Meeting 2021, 07 Haziran 2021, (Özet Bildiri)

18. Semisolid NLC dispersions: QbD based formulation optimization and ex vivo – in vivo evaluation

AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., AKSU N. B., BEŞİKCİ A., TARIMCI M. N.

EUFEPS Virtual Annual Meeting 2021 – Bridging the gap between the patient and product design, İsveç, 7 - 09 Haziran 2021, (Özet Bildiri)

19. Effects of Cucurbitacin B Hybrid Nanocarriers on Apoptosis of MDAMB231 Cells Through PARP Cleavage

BAKAR ATEŞ F., ÖZKAN E., ŞENGEL TÜRK C. T.

7th International Drug Chemistry Conference, 14 - 17 Mart 2019, (Özet Bildiri)

20. Formulation Design and Cytotoxic Effects of Cucurbitacin B Encapsulated Lipid-Polymer Hybrid Nanocarriers

ŞENGEL TÜRK C. T., ÖZMEN N., BAKAR ATEŞ F.

7th International Drug Chemistry Conference, 14 - 17 Mart 2019, (Özet Bildiri)

21. Cucurbitacin B Loaded Lipid Polymer Hybrid Nanocarriers Induced a Significant Decrease in Mitochondrial Membrane Potential in  Breast Cancer Cells

BAKAR ATEŞ F., ÖZKAN E., ŞENGEL TÜRK C. T.

HDIR-5 Meeting, Zagreb, Hırvatistan, 8 - 10 Kasım 2018, (Özet Bildiri)

22. ANTICANCER EFFECT OF CUCURBITACIN B LOADED HYBRID NANOCARRIERS ON HUMAN BREAST CANCER CELLS

BAKAR ATEŞ F., ÖZKAN E., ŞENGEL TÜRK C. T.

TBD Uluslararası Biyokimya Kongresi - 29. Ulusal Biyokimya Kongresi, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri)

23. PREPARATION OF CUCURBITACIN B ENCAPSULATED LIPID POLYMER HYBRID NANOCARRIERS AND EVALUATION OF THEIR CYTOTOXIC EFFECTS

ŞENGEL TÜRK C. T., ÖZMEN N., BAKAR ATEŞ F.

19th International Pharmaceutical Technology Symposium, 17 - 19 Eylül 2018, (Özet Bildiri)

24. Preparation and Optimization of Cucurbitacin B Loaded Core-Shell Type Hybrid Nanoparticles Using a Full Factorial Design Study

ŞENGEL TÜRK C. T., ÖZMEN N., BAKAR ATEŞ F.

12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, ss.289, (Özet Bildiri)

25. Design and in-vitro cell-based evaluation of lonidamine-loaded vitamin E TPGS-conjugated polymeric nanoparticles

BAKAR ATEŞ F., ŞENGEL TÜRK C. T.

The 43rd FEBS Congress, 7 - 12 Temmuz 2018, ss.249, (Özet Bildiri)

26. Validation of HPLC Methods for the Analysis of Nanoparticle Based Drug Delivery Systems

GÜMÜŞTAŞ M., AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., TARIMCI M. N., ÖZKAN S. A.

8-th Annual Symposium onPhysical and Analytical Chemistry (8th ASPAC), Tiflis, Gürcistan, 28 - 29 Aralık 2017, (Özet Bildiri)

27. Validation of HPLC Method for the Analysis of Nanoparticle Based Drug Delivery Systems

GÜMÜŞTAŞ M., AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., TARIMCI M. N., ÖZKAN S. A.

8th Annual Symposium on Physical and Analytical Chemistry at Tbilisi State University, 28 - 29 Aralık 2017, (Özet Bildiri)

28. Design and Optimization of Fluticasone Propionate Loaded Solid Lipid Nanoparticles by 32 Factorial Design

AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., TARIMCI M. N.

2nd International Gazi Pharma Symposium Series (GPSS 2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

29. Design and optimization of fluticasone propionate loaded solid lipid nanoparticles by factorial design

AMASYA G., ŞENGEL TÜRK C. T., BADILLI F. U., TARIMCI M. N.

2nd International Gazi Pharma Symposium, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

30. Antiproliferative Activity and Safety of Lonidamine Encapsulated PEG-block-PCL Nanocarriers Against SW480 Colon Cancer Cells

ŞENGEL TÜRK C. T., BAKAR F.

VI. International Congress of Molecular Medicine, İstanbul, Türkiye, 22 - 25 Mayıs 2017, (Özet Bildiri)

31. Design and In-Vivo Based Evaluation of Lonidamine Loaded Hybrid Nanoparticles for Treatment of Bening Prostatic Hyperplasia

ŞENGEL TÜRK C. T., HASÇİÇEK C., EKİM O., ALÇIĞIR M. E., BAKAR ATEŞ F.

22nd International Biomedical Science & Technology Symposium BİOMED 2017, 12 Mayıs 2017, (Tam Metin Bildiri)

32. Design and In-vivo Model Based Evaluation of Lonidamine Loaded Hybrid Nanoparticlesfor Treatment of Benign Prostatic Hyperplasia

ŞENGEL TÜRK C. T., HASÇİÇEK C., EKİM O., ALÇIĞIR M. E., BAKAR ATEŞ F.

22th International Biomedical Science Technology Symposium, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)

33. Design and In vivo Model Based Evaluation of Lonidamine Loaded Hybrid Nanoparticles for Treatment of Benign Prostatic Hyperplasia

ŞENGEL TÜRK C. T., HASÇİÇEK C., EKİM O., ALÇIĞIR M. E., BAKAR ATEŞ F.

22nd International Biomedical Science Technology Symposium (BIOMED- 2017), Ankara, Türkiye, 12 - 14 Mayıs 2017, (Özet Bildiri)

34. ANTIPROLIFERATIVE POTENTIAL OF NANOPARTICLE BASED DELIVERY SYSTEM OF FULVESTRANT ON MCF 7 HUMAN BREAST CANCER CELLS

HASÇİÇEK C., ŞENGEL TÜRK C. T., BAKAR F., EVCİMEN N., GÜMÜŞTAŞ M., ÖZKAN S. A., et al.

2016 AAPS Annual Meeting and Exposition, 13 - 17 Kasım 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

35. Benign prostat hiperplazisinin tedavisine yönelik lipit-polimer sistemlerin geliştirilmesi ve değerlendirilmesi

ŞENGEL TÜRK C. T., HASÇİÇEK C., EKİM O., ALÇIĞIR M. E.

1. Ulusal Marmara Eczacılık Kongresi, Türkiye, 3 - 05 Kasım 2016, (Özet Bildiri)

36. Dermal behaviour of semisolid SLN dispersions of etofenamate

BADILLI F. U., ŞENGEL TÜRK C. T., AMASYA G., TARIMCI M. N.

International Gazi Pharma Symposium, Antalya, Türkiye, 12 - 15 Kasım 2015, (Özet Bildiri)

37. Design and characterization of hibrid nanaoparticulate systems for tratment of benigh prostatic hyperplasia

ŞENGEL TÜRK C. T., HASÇİÇEK C.

International Gazi Pharma Symposium (GPSS 2015), 12 - 15 Ekim 2015

38. Optimization of sensitive and selective RP LC method for the determination of etofenamate from rat skin

AMASYA G., GÜMÜŞTAŞ M., ŞENGEL TÜRK C. T., BADİLLİ U., ÖZKAN S. A., TARIMCI M. N.

The European Conference on Analytical Chemistry 18, Euroanalysis 2015, 6 - 10 Eylül 2015

39. Occlusive and mechanical characteristics of etofenamate encapsulated semisolid SLN formulations

BADILLI F. U., ŞENGEL TÜRK C. T., AMASYA G., TARIMCI M. N.

11th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 9 - 12 Haziran 2015, (Özet Bildiri)

40. Development and Evaluation of a Lipid Polymer Hybrid Nanoparticulate System

ŞENGEL TÜRK C. T., HASÇİÇEK C.

11th International Symposium on Pharmaceutical Sciences (ISOPS-11), Ankara, Türkiye, 9 - 12 Haziran 2015

41. Fulvestrantin Ters Faz Sıvı Kromatografik Yöntemle Biyolojik Sıvılar ve Polimerik Bazlı Nanopartikullerden Analizi

GÜMÜŞTAŞ M., ŞENGEL TÜRK C. T., HASÇİÇEK C., ÖZKAN S. A., BAKAR ATEŞ F., EVCİMEN N., et al.

15. Ulusal Kromatografi Kongresi (Kromatografi 2015), Türkiye, 8 - 10 Nisan 2015, (Tam Metin Bildiri)

42. Fulvetrantin Ters Faz Sivi Kromatografik Yontemle Biyolojik Sivilar ve Polimerik Bazli Nanopartikullerden Analizi

GÜMÜŞTAŞ M., ŞENGEL TÜRK C. T., HASÇİÇEK C., ÖZKAN S. A., BAKAR F., EVCİMEN N., et al.

15. Ulusal Kromatografi Kongresi (Kromatografi 2015), Türkiye, 8 - 10 Nisan 2015

43. Fulvestrant ın Ters Faz Sıvı Kromatografik Yöntemle Biyolojik Sıvılar ve Polimerik Bazlı Nanopartiküllerden Analizi

GÜMÜŞTAŞ M., ŞENGEL TÜRK C. T., HASÇİÇEK C., ÖZKAN S. A., BAKAR F., EVCİMEN N., et al.

15.Ulusal Kromatografi Kongresi Uşak Üniversitesi Mühendislik Fakültesi Gıda Mühendisliği Bölümü, AFYON, Türkiye, 8 - 10 Nisan 2015, (Özet Bildiri)

44. Comparative Study of Losartan Potassium Release From Matrix Tablets with Kollidon SR or Ethylcellulose

ERGİN A. D., Eren T., TURHAN F., ŞENGEL TÜRK C. T., HASÇİÇEK C.

3rd Conference on Innovation in Drug Delivery Advances in Local Drug Delivery (APGI-2013), Roma, 22 - 25 Eylül 2014

45. Fabrication Of Fulvestrant Loaded Modified Released Nanoparticles: Effect Of Copolymer Molecular Weight On Particle Characteristics

HASÇİÇEK C., ŞENGEL TÜRK C. T., BAKAR F., EVCİMEN N., GÜMÜŞTAŞ M., ÖZKAN S. A.

4 Th International Meeting On Pharmacy Pharmaceutical Sciences (Impps-4), 18 - 21 Eylül 2014, (Özet Bildiri)

46. Fulvestrant Loaded Plga Nanoparticles: Influence Of Polymer Copolymer Composition On In-Vitro Properties And Anti-Proliferative Potencies Against Mcf-7 Breast Cancer Cells

HASÇİÇEK C., ŞENGEL TÜRK C. T., BAKAR F., EVCİMEN N., GÜMÜŞTAŞ M., ÖZKAN S. A.

17 th International Pharmaceutical Technology Symposium, 8 - 10 Eylül 2014, (Özet Bildiri) Sürdürülebilir Kalkınma

47. Fabrication of Fulvestrant loaded modified released nanoparticles: comparison of copolymer molecular weight on particle characteristics

HASÇİÇEK C., ŞENGEL TÜRK C. T., GÜMÜŞTAŞ M., ÖZKAN S. A., SAVAŞER A., ÖZKAN Y.

13 th European Symposium on Controlled Drug Delivery, Egmond aan Zee, Hollanda, 16 - 18 Nisan 2014, (Özet Bildiri)

48. The Effect of Fulvestrant to Aromatase Activity on Human Preadipocyte Cells

BAKAR F., Net D. E., ŞENGEL TÜRK C. T., HASÇİÇEK C.

EACR- Sponsored 2nd Anticancer Agents Congress & 5th Multidisciplinary Cancer Research Congress, Bodrum, Türkiye, 23 - 24 Nisan 2014

49. Fabrication of Fulvestrant Loaded Modified Released Nanoparticles Comparison of Copolymer Molecular Weight

HASÇİÇEK C., ŞENGEL TÜRK C. T., GÜMÜŞTAŞ M., ÖZKAN S. A., Ayhan S., ÖZKAN Y.

13th European Symposium on Controlled Drug Delivery, 16 - 18 Nisan 2014

50. A Systematic Study of PLGA Nanoparticles Part II Effect Of Formulation Variables On Particle Characteristics

SERİM T. M., ÖZ U. C., ŞENGEL TÜRK C. T., HASÇİÇEK C.

FIP World Congress, Towards a future vision for complex patients: Integrated care in a dynamic continuum (FIP-2013), Dublin, İrlanda, 31 Ağustos - 05 Eylül 2013

51. A systemic study of PLGA nanoparticles: Part II. Effect of formulation variables on particle characteristics

SERİM T. M., ÖZ U. C., ŞENGEL TÜRK C. T., HASÇİÇEK C.

73rd International Congress of FIP, World Congress of Pharmacy and Pharmaceutical Sciences, Dublin, İrlanda, 31 Ağustos - 05 Eylül 2013, (Özet Bildiri)